Journey Medical Corp Interest Expense
Journey Medical Corp (DERM) reported Interest Expense of $548.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-14
- Journey Medical Corp interest expense for the quarter ending 2024-03-31 was $548.00K, a 15.69% decline year-over-year.
- Journey Medical Corp interest expense for the quarter ending 2023-12-31 was $24.00K, a 96.11% decline year-over-year.
- Journey Medical Corp interest expense for the quarter ending 2023-09-30 was $268.00K, a 52.06% decline year-over-year.
- Journey Medical Corp interest expense for the quarter ending 2023-06-30 was $756.00K, a 66.52% increase year-over-year.
- Journey Medical Corp interest expense for fiscal 2023 was $1.70M, a 15.90% decline from fiscal 2022.
- Journey Medical Corp interest expense for fiscal 2022 was $2.02M, a 71.30% decline from fiscal 2021.
- Journey Medical Corp interest expense for fiscal 2021 was $7.03M, a 907.74% increase from fiscal 2020.
- Journey Medical Corp interest expense for fiscal 2020 was $698.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $548.00K 10-Q · filed 2024-05-14 | $572.00K derived: sum of 2 quarters · filed 2024-05-14 | $840.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.60M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $292.00K derived: sum of 2 quarters · filed 2024-03-29 | $1.05M derived: sum of 3 quarters · filed 2024-03-29 | $1.70M 10-K · filed 2024-03-29 |
| 2023-09-30 | $268.00K 10-Q · filed 2023-11-13 | $1.02M derived: sum of 2 quarters · filed 2023-11-13 | $1.67M 10-Q · filed 2023-11-13 | $2.29M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $756.00K 10-Q · filed 2023-08-10 | $1.41M 10-Q · filed 2023-08-10 | $2.02M derived: sum of 3 quarters · filed 2024-05-14 | $2.58M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $650.00K 10-Q · filed 2024-05-14 | $1.27M derived: sum of 2 quarters · filed 2024-05-14 | $1.83M derived: sum of 3 quarters · filed 2024-05-14 | $2.28M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.18M derived: sum of 2 quarters · filed 2024-03-29 | $1.63M derived: sum of 3 quarters · filed 2024-03-29 | $2.02M 10-K · filed 2024-03-29 |
| 2022-09-30 | $559.00K 10-Q · filed 2023-11-13 | $1.01M derived: sum of 2 quarters · filed 2023-11-13 | $1.40M 10-Q · filed 2023-11-13 | $5.50M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $454.00K 10-Q · filed 2023-08-10 | $843.00K 10-Q · filed 2023-08-10 | $4.94M derived: sum of 3 quarters · filed 2023-08-10 | $6.31M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $389.00K 10-Q · filed 2023-05-22 | $4.49M derived: sum of 2 quarters · filed 2023-05-22 | $5.86M derived: sum of 3 quarters · filed 2023-05-22 | $7.20M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.47M derived: sum of 2 quarters · filed 2023-03-31 | $6.81M derived: sum of 3 quarters · filed 2023-03-31 | $7.03M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.37M 10-Q · filed 2022-11-10 | $2.71M derived: sum of 2 quarters · filed 2022-11-10 | $2.94M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.34M 10-Q · filed 2022-08-09 | $1.56M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $221.00K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $698.00K 10-K · filed 2022-03-28 |